4//SEC Filing
Horan Christopher 4
Accession 0001193125-25-317982
CIK 0001817241other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 7:20 PM ET
Size
21.8 KB
Accession
0001193125-25-317982
Insider Transaction Report
Form 4
Horan Christopher
Chief Tech Operations Officer
Transactions
- Award
Common Stock
2025-12-12+107,156→ 185,339 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−77,519→ 0 totalExercise: $5.01Exp: 2033-04-02→ Common Stock (77,519 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−9,119→ 0 totalExercise: $5.01Exp: 2033-05-23→ Common Stock (9,119 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-12-12−20,519→ 0 totalExercise: $13.47Exp: 2034-05-01→ Common Stock (20,519 underlying)
Footnotes (5)
- [F1]Represents restricted stock units award granted under the Issuer's 2024 Equity Incentive Plan ("RSUs").
- [F2]On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I.
- [F3]25% of the shares vested on December 31, 2022, and the remaining shares vest in 36 equal monthly installments thereafter.
- [F4]Vesting is monthly over a 48-month period starting May 24, 2023 in equal monthly amounts.
- [F5]25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Artiva Biotherapeutics, Inc.
CIK 0001817241
Entity typeother
Related Parties
1- filerCIK 0001736819
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 7:20 PM ET
- Size
- 21.8 KB